NCT05373680 Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression Status COMPLETED Phase PHASE2/PHASE3
NCT05366868 Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05351021 Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT05345327 SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT05332795 The Impact of Metformin on the Outcome of Gouty Arthritis in a Cohort of Egyptian Gouty Patients. Status COMPLETED Phase NA
NCT05326984 Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia Status UNKNOWN Phase NA
NCT05305898 "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome Status RECRUITING Phase PHASE3
NCT05292573 Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia Status RECRUITING Phase PHASE3
NCT05288153 Metformin Efficacy and Safety for Gastric Intestinal Metaplasia Status COMPLETED Phase PHASE4
NCT05280496 A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes Status COMPLETED Phase PHASE3
NCT05262257 Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus. Status UNKNOWN Phase EARLY_PHASE1
NCT05243654 Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy Status RECRUITING Phase PHASE2
NCT05240274 The POWERED Study: Prophylaxis With Metformin to Prevent PTDM Status COMPLETED Phase PHASE2
NCT05236530 Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir Status COMPLETED Phase PHASE1
NCT05183204 Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma Status SUSPENDED Phase PHASE2
NCT05182970 Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) Status RECRUITING Phase PHASE3
NCT05102071 Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas Status WITHDRAWN Phase N/A